These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23449110)

  • 1. Autoimmunity, end organ damage, and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus.
    Lewis JE; Fu SM; Gaskin F
    Discov Med; 2013 Feb; 15(81):85-92. PubMed ID: 23449110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR.
    Fu SM; Deshmukh US; Gaskin F
    J Autoimmun; 2011 Sep; 37(2):104-12. PubMed ID: 21632208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2005 Sep; 17(5):523-8. PubMed ID: 16093828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD.
    Deshmukh US; Sim DL; Dai C; Kannapell CJ; Gaskin F; Rajagopalan G; David CS; Fu SM
    J Autoimmun; 2011 Nov; 37(3):254-62. PubMed ID: 21868195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells biology in systemic lupus erythematosus-from bench to bedside.
    Zhao L; Ye Y; Zhang X
    Sci China Life Sci; 2015 Nov; 58(11):1111-25. PubMed ID: 26563177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can killers be saviors?
    Singh G; Agarwal AK; Prosek J; Jayadev MSK; Singh A
    Lupus; 2017 Aug; 26(9):903-908. PubMed ID: 28121242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification.
    Zhao Z; Ren J; Dai C; Kannapell CC; Wang H; Gaskin F; Fu SM
    Ann Rheum Dis; 2019 Mar; 78(3):380-390. PubMed ID: 30254034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic idiotypes of autoantibodies in autoimmunity: lessons from new experimental models of SLE.
    Shoenfeld Y; Mozes E
    FASEB J; 1990 Jun; 4(9):2646-51. PubMed ID: 2140806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and systemic lupus erythematosus.
    James JA; Harley JB; Scofield RH
    Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.
    Moulton VR; Suarez-Fueyo A; Meidan E; Li H; Mizui M; Tsokos GC
    Trends Mol Med; 2017 Jul; 23(7):615-635. PubMed ID: 28623084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus.
    Singh RR; Ebling FM; Sercarz EE; Hahn BH
    J Clin Invest; 1995 Dec; 96(6):2990-6. PubMed ID: 8675671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging and critical issues in the pathogenesis of lupus.
    Gatto M; Zen M; Ghirardello A; Bettio S; Bassi N; Iaccarino L; Punzi L; Doria A
    Autoimmun Rev; 2013 Feb; 12(4):523-36. PubMed ID: 23000207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of systemic lupus erythematosus-an update.
    Choi J; Kim ST; Craft J
    Curr Opin Immunol; 2012 Dec; 24(6):651-7. PubMed ID: 23131610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selfie: Autoimmunity, boon or bane.
    Ahsan H
    J Immunoassay Immunochem; 2017; 38(3):235-246. PubMed ID: 28421864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant B cell selection and activation in systemic lupus erythematosus.
    Kil LP; Hendriks RW
    Int Rev Immunol; 2013 Aug; 32(4):445-70. PubMed ID: 23768157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do naturally occurring autoantibodies participate in the constitution of the pathological B-cell repertoire in systemic lupus erythematosus?
    Gilbert D; Brard F; Jovelin F; Tron F
    J Autoimmun; 1996 Apr; 9(2):247-57. PubMed ID: 8738970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus.
    Park MJ; Lee SH; Kim EK; Lee EJ; Park SH; Kwok SK; Cho ML
    Arthritis Rheumatol; 2016 Nov; 68(11):2717-2727. PubMed ID: 27214349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of kidney disease in systemic lupus erythematosus.
    Bagavant H; Fu SM
    Curr Opin Rheumatol; 2009 Sep; 21(5):489-94. PubMed ID: 19584729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity.
    Stohl W; Jacob N; Quinn WJ; Cancro MP; Gao H; Putterman C; Gao X; Pricop L; Koss MN
    J Immunol; 2008 Jul; 181(1):833-41. PubMed ID: 18566449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.